The Global Plasma Market to 2016: Vendors Solidify Position through Market Consolidation

DUBLIN, July 25, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/93mmw5/global_plasma) has announced the addition of the "Global Plasma Market 2012-2016" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

This report forecasts the Global Plasma market to grow at a CAGR of 10.31 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the aging population. The Global Plasma market has also been witnessing the trend of increasing market consolidation. However, stringent regulations could pose a challenge to the growth of this market.

This report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global plasma market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this space include CSL Behring LLC, Baxter International Inc., Grifols S.A., and Octapharma AG.

Other vendors mentioned in the report are Kedrion S.p.A., Biotest AG, Sanguine Corp., Cangene bioPharma Inc., Haemacure Corp., Kamada Inc., Omrix Biopharmaceuticals Inc., Vivostat A/S, Pfizer Inc., AstraZeneca plc, Takeda Pharmaceutical Inc., Novo Nordisk A/S, sanofi S.A., China Biologic Products Inc., Beijing Tiantan Biological Products Co. Ltd., Bharat Serums and Vaccines Ltd., and LFB Group.

Key questions answered in this report:

- What will the market size be in 2016 and at what will be the growth rate?

- What are key market trends?

- What is driving this market?

- What are the challenges to market growth?

- Who are the key vendors in this market space?

- What are the market opportunities and threats faced by key vendors?

- What are the strengths and weaknesses of each of these key vendors?

Commenting on the report, an analyst from TechNavio's Healthcare team said: "Over the years, the Global Plasma market has been witnessing significant consolidation and as a result the positions of the leading players have shifted dramatically over the past decade. This trend is expected to continue during the forecast period as vendors attempt to strengthen or hold their market position. Market consolidation has resulted in stronger competitors that are better able to compete as sole-source vendors to end-users. For instance, Australia-based CSL Behring has become one of the world's leading fractionators through a series of acquisitions including its 2000 buyout of ZLB Behring and 2004 purchase of Aventis Behring. Grifols acquisition of Talecris Biotherapeutics has further consolidated the industry."

According to the report, one of the major drivers is the increase in the aging population, which will lead to an increase in the number of immune deficiency patients.

Further, the report states that one of the most important challenges in the market is the stringent regulations with respect to the selection of donors, plasma screening process, and fractionation process.

The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this market space are Baxter International Inc., CSL Behring LLC, Grifols S.A., and Octapharma AG.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For more information visit http://www.researchandmarkets.com/research/93mmw5/global_plasma

Research and Markets
Laura Wood, Senior Manager
[email protected]
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

SOURCE Research and Markets